Diagnóstico bioquímico de las dislipemias en el adulto

Acta Bioquimica Clinica Latinoamericana

Volumn 35, Issue 2, 2001, Pages 225-236

  Schreier, Laura ^a   Berg, Gabriela ^b   Brites, Fernando ^b   Graciela Lopez I ^b   Sanguinetti, Silvia ^b   Aisemberg, Laura ^b   González, Ana I ^b   Paglione, Ana M ^b   Wikinski, Regina ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE

Author keywords

Diagnosis of dyslipidemias; Lipid profile; Lipoproteins; Modified lipoproteins; Reference values and outpoints

Indexed keywords

EID: 0142217582     PISSN: 03252957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. FREDRICKSON SD and LEES RS: "System for phenotyping hyperlipoproteinemia." Circulation, 31,321-327, 1965.
2. FREDRICKSON SD, LEVY RI and LEES RS: "Fat transport in lipoproteins-An integrated approach to mechanisms and disorders." N Engl J Med, 276,32-281,1967.
3. KANNEL WB. "Contributions of the Framingham Study to the conquest of coronary artery disease". Am J Cardiol, 62, 1109-1112,1988.
4. CASTELLI WP. "Lipids, risk factors and ischaemic heart disease". Atherosclerosis,124,S1-S9,1996.
5. Scandinavian Simvastatin Survival Group. "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S)". Lancet, 344,1383-1389, 1994.
6. HOKANSON JE and AUSTIN MA. "Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies." J Cardiovasc Risk, 3, 213-219, 1996.
7. WIKINSKI R, MOROCOIMA Z and CAMEJO M. "Pre-and post-prandial levels of intermediate density lipoproteins in Type 2 diabetic female patients." Medicina,46,51-54, 1986.
8. ZILVERSMIT DB. "Atherogenesis: a postprandial phenomenon". Circulation,60,473-485,1979
9. BROWN SA, EPPS DF, DUNN J, SHARRET AR, PATSCH JR, Gotto AM and PATSCH W. Effect of blood collection and processing on radioimmunoassay results for apolipoprotein B in plasma. Clin Chem,36,1662-1666, 1990.
10. "Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education Program (NCEP) expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults." JAMA,269,3015-3023, 1993.
11. CONIGLIO RI, DAHINTEN E, VIDAL EJ, SALGUEIRO AM, OTERO JC, VASQUEZ LA, MARCHESELLI C y ZAVALEY S. "Prevalencia de los factores de riesgo para las enfermedades cardiovasculares en zonas urbanas de la Patagonia Argentina. Estudio Multicéntrico." Medicina, 52, 320-332, 1992.
12. Grundy SM, BALADY GJ, CRIQUI MH, FLETCHER G, GREENLAND P, HIRATZKA LF, HOUSTON-MILLER N, KRIS-ETHERTON P, KRUMHOLZ HM, LAROSA H, OCKENE IS, PEARSON TA, REED J, WASHINGTON R and SMITH SC. "Guide to Primary Prevention of Cardiovascular Diseases. A statment for healthcare professionals from the Task Force on Risk Reduction". Circulation,95,2329-2331, 1997.
13. AUSTIN MA, KING Mc, VRANIZAN KM, KRAUSS RM. "Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease rish." Circulation, 82, 495-506,1990.
14. ASSMANN G and SCHULTE H. "Role or triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study." Am J Cardiol,70,10H-13H, 1992.
15. ASSMANN G, SCHULTE H, VON ECKARDSTEIN A and HUANG Y. "High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport." Atherosclerosis,124,S11-S20, 1996.
16. GENEST JJ, MARTIN-MUNLEY SS and MCNAMARA JR. "Familial lipoprotein disorders in patients with premature coronary artery disease." Circulation,85,2025, 1992.
17. CASTELLI W. "Epidemiology of coronary heart disease. The Framingham Study." Am J Med,76,4-9,1984.
18. NIKKILA M and HEIKKINEN J. "High density lipoprotein cholesterol and longevity." Age Ageing,19,119-124,1990.
19. ROSENTAL S, BRITES FD and WIKINSKI RLW. "Assessment of High-Density Lipoprotein cholesterol in Hypertrigliceridemic sera". Clin Chem,39,1350-1352, 1993.
20. TUCKER LA and FRIEDMAN GM. "Walking and serum cholesterol in adults. Am J Public Health,80,111-1113, 1990.
21. GAZIANO JM, BURING JE and BRESLOW JL. Moderate alcohol intake, increased levels of high density lipoprotein and its subfractions, and decreased risk of myocardial infarction." N Engl J Med,329,1829-1834, 1993.
22. The Writing Group for the PEPI trial. "Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in post-menopausal women." JAMA, 273,199-208,1995.
23. RIGOTTI NA and PASTERNAK RC. "Cigarette smoking and coronary heart disease: risks and management." Cardiol Clin, 14,51-68,1996.
24. BERG A, HALLE M, FRANZ I and KEUL J. "Physical activity and lipoprotein metabolism: epidemiological evidence and clinical trials (review)." Eur J Med Res,2,259-264,1997.
25. KARHAPAA P, MALKKI M and LAAKSO M. "Isolated low HDL cholesterol: an insulin-resistance state." Diabetes,43,411-417, 1994.
26. JOHANSON J, CARLSON LA and LANDOU C. "High density lipoproteins and coronary atherosclerosis: a strong inverse relation with the largest particles is confined to normotriglyceridemic patients." Arterioscler Thromb, 11,174-182, 1991.
27. KRAUSS RM. Regulation of high density lipoprotein levels. Med Clin North Amer, 66,403-430,1982.
28. CHEUNG M and ALBERS JJ. "Characterization of lipoprotein particles by immunoaffinity chromatography: particles containing A-I and A-II and particles containing A-I but no A-II." J Biol Chem, 259, 12201,1984.
29. BARKIA A, PUCHOIS P, GHALIM N, TORPIER G, AILHAUD G and FRUCHART JC. "Differenial role of apolipoprotein A-I containing particles in cholesterol efflux from adipose cells." Atherosclerosis,87,135-146,1991.
30. PAGLIONE AM, JUAREZ PEÑALVA H, SCHREIER L, LOPEZ G y VAL A. "Enfermedad coronaria: nuevos parámetros bioquímicos. Utilidad de las apolipoproteínas A1 y B." Acta Bioquim. Clin Latioam,28,469-478,1984.
31. MCBRIDE P, SCHROTT HG and PLANE MB. "Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease." Arch Intern Med,158,1238-1244,1998.
32. FRIEDEWALD WT, LEVY RI and FREDRICKSON DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 18(6), 499-502, 1972.
33. MILLER WG. "Matrix effects in the measurement and standardization of lipids and lipoproteins." In Handbook of Lipoprotein testing. Eds. Rifai N, Warnick GR, Dominczak MH. AACC Press, 1997.
34. BANCHIC ME, PAGLIONE AM, FAGNANI G Y WIKINSKI R. Determinación cuantitativa de las lipoproteínas plasmáticas por electroforesis en gel de agarosa. "Revista A.B.A", 38;84-91;1973.
35. HALPERIN H, STOLIAR A, GROSMAN H y WIKINSKI R. "Separación electroforética de las lipoproteínas plasmáticas en gel de poliacrilamida." Revista A.B.A, 39,16-30, 1974.
36. WIKINSKI RLW, SCHREIER LE and ROSENTAL SB. "New method for isolating and quantifying intermediate and β-Very Low Density Lipoprotein cholesterol." Clin Chem, 37,1913-1916,1991.
37. SCHREIER L, BERG G, ROSENTAL SB, CORREA V, LOPEZ GI, BRITES F, PANDOLFO M, HALPERIN H, PAGLIONE AM y WIKINSKI RLW. "Colesterol-IDL y/o b-VLDL: Un nuevo parámetro en diferentes fenotipos lipoproteicos." Acta Bioq Clin Latioam,27,65-74, 1993.
38. WIKINSKI R, HENAO L, RIVAS FIGUEROA C, ARCAVI M, DE MADEROS GC, DE SUAREZ IT and COLL GARCIA E. "Detection of intermediate density lipoprotein in the plasma of diabetic patients." Medicina,42,265-272, 1982.
39. WIELAND H and SEIDEL D. "Improved techniques for assessment of serum lipoprotein patterns. II Rapid method for diagnosis of Type III hyperlipoproteinemia without ultracentrifugation." Clin Chem,19,1139-1141,1973.
40. MOSSO H, IBARRA R, WIKINSKI R, PAGLIONE AM, MOLLERACH M, TORRALES MR y VENTININQUE R "Etiopatogenia de la ateroësclerosis." EUDEBA, Buenos Aires, 103,1981.
41. TATE JR, RIFAI N, BERG K, COUDERC R, DATI F, KOSTNER G, SAKURABAYASHI I and STEINMETZ A. "International Federation of Clinical Chemistry standardization project for the measurement of lipoprotin (a). Phase 1. Evaluation of the analytical performance of lipoprotein (a) assay systems and commercial calibrators." Clin Chem,44,1629-1640,1998.
42. ZAVALA A, PAGLIONE AM, SCHREIER L y PUPI R. "Valor de las Apoproteinas como factor de predicción de la vasculopatía periférica en los diabéticos." Nutrición., 1, 15-17,1983.
43. LENA VEGA G, BELTZ WF and GRUNDY SM. "Low density lipoprotein metabolism in hypertriglyceridemic and normolipidemic patients with coronary heart disease." J Lipid Res,26,115-126, 1985.
44. LENA VEGA G, ILLINGWORTH R, GRUNDY SM, LINDGREN FT and CONNOR WE. "Normocholesterolemic Tendon Xanthomatosis with overproduction of apolipoprotein B." Metabolism,32,118-125,1983.
45. CONIGLIO R. "Efecto de las lipoproteínas ricas en triglicéridos sobre la relaciön entre C-LDL y apoB determinada por EID en suero total. Indicadores de riesgo para la enfermedad coronaria. Valores de ApoB/C-HDL." Acta Bioq Clin Latinoam, 24,147-158,1990.
46. AUSTIN MA and EDWARDS KL. "Small, dense low density lipoproteins the insulin resistance syndrome and non insulin dependent diabetes." Curr Opin Lipidol, 7,167-171,1996.
47. FASULO V., SANGUINETTI S., WIKINSKI R. y SCHREIER L. "Caracterización de LDL densa (LDL-H)." Medicina,58 (5),654, 1998.(Resumen)
48. FURUYA D, YAGIHASHI A, NASU S, ENDOH T, NAKAMURA T, KANEKO R, KAMAGATA C, KOBAYASHI D and WATANABE N. "LDL particle size by gradient-gel electrophoresis cannot be estimated by LDL-cholesterol/apolipoprotein B ratios." Clin Chem, 46,1202-1203,2000.
49. RAINWATER D, ANDREI D, ALLEN L F, LOWE WF, BLANCHE P and KRAUSS R. "Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins." J Lipid Res,33,1876-1881,1992.
50. FASULO V., SANGUINETTI S., WIKINSKI R. y SCHREIER L. "LDL pequeña y densa y trigliceridemia en diabetes tipo 2." Actas Congreso Nacional de Bioquímicos Cubra V. 1999. (Resumen)
51. SCHREIER L, SANGUINETTI S, MOSSO H, LOPEZ G, SIRI L and WIKINSKI R. "Low Density lipoprotein composition and oxidability in Atherosclerotic Cardiovascular Disease." Clinical Biochem, 29, 479-487,1996.
52. NILSSON EHLE P. and EKMAN R. "Rapid, Simple and Specific assay for lipoprotein lipase and hepatic lipase." Artery, 3,194-199, 1977.
53. UTERMAN G. "Apolipoprotein E polymorphism in health and disease." Am Heart J, 113, 433-440, 1987.
54. MAHLEY RW, INNERARITY TL, RALL JSC, WEISGRABER KH and TAYLOR JM. "Apolipoprotein E: genetic variants provide insights into its structure and function." Curr Opin Lipidol, 1,87-95,1990.
55. Eto M, Watanabe K and Ishii K. "Apolipoprotein E alleles and hyperlipoproteinemia in Japan." Clin Genet, 34, x246-251, 1988.
56. SAUNDERS AM, SCHMADER K, BREITER JCS, BENSON MD, BROWN WT and GOLDFARB L. "Apolipoprotein e4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases." Lancet, 342, 710-711, 1993.